tiprankstipranks
Trending News
More News >
Dynavax Technologies Corp. (DVAX)
NASDAQ:DVAX
US Market

Dynavax (DVAX) Stock Forecast & Price Target

Compare
2,422 Followers
See the Price Targets and Ratings of:

DVAX Analyst Ratings

Moderate Buy
4Ratings
Moderate Buy
3 Buy
0 Hold
1 Sell
Based on 4 analysts giving stock ratings to
Dynavax
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DVAX Stock 12 Month Forecast

Average Price Target

$22.00
▲(121.11%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Dynavax in the last 3 months. The average price target is $22.00 with a high forecast of $31.00 and a low forecast of $10.00. The average price target represents a 121.11% change from the last price of $9.95.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","14":"$14","20":"$20","26":"$26","32":"$32"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,14,20,26,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Oct<br/>2024","9":"Feb<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.84,11.467692307692307,13.095384615384615,14.723076923076924,16.35076923076923,17.978461538461538,19.606153846153845,21.233846153846155,22.861538461538462,24.48923076923077,26.116923076923076,27.744615384615386,29.372307692307693,{"y":31,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.84,10.775384615384615,11.71076923076923,12.646153846153846,13.581538461538461,14.516923076923078,15.452307692307691,16.38769230769231,17.323076923076922,18.25846153846154,19.193846153846152,20.12923076923077,21.064615384615387,{"y":22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.84,9.852307692307692,9.864615384615384,9.876923076923077,9.88923076923077,9.901538461538461,9.913846153846153,9.926153846153847,9.938461538461539,9.95076923076923,9.963076923076922,9.975384615384616,9.987692307692308,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.26,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.38,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.78,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.68,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.99,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.91,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.77,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.05,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.84,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$31.00Average Price Target$22.00Lowest Price Target$10.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DVAX
TipRanks AITipRanks
Not Ranked
TipRanks
$9.5
Hold
-4.52%
Downside
Reiterated
05/15/25
Dynavax's overall score is affected by weak financial performance due to declining revenues and net losses, which are somewhat offset by a strong balance sheet and adequate cash flow management. Technical indicators are bearish, and the stock's valuation is unappealing due to the negative P/E ratio. The earnings call provides a positive outlook with revenue growth and strategic advancements, which somewhat mitigates the financial and technical weaknesses. Continued focus on growth and cost management will be key to improving the company's financial health.
William Blair Analyst forecast on DVAX
Matt PhippsWilliam Blair
William Blair
Buy
Reiterated
06/04/25
William Blair Keeps Their Buy Rating on Dynavax (DVAX)
Citizens JMP Analyst forecast on DVAX
Roy BuchananCitizens JMP
Citizens JMP
$33$31
Buy
211.56%
Upside
Reiterated
05/07/25
Dynavax price target lowered to $31 from $33 at Citizens JMPDynavax price target lowered to $31 from $33 at Citizens JMP
TD Cowen Analyst forecast on DVAX
Phil NadeauTD Cowen
TD Cowen
$25
Buy
151.26%
Upside
Reiterated
05/06/25
Strong Buy Rating for Dynavax Amidst Promising Growth and Market Prospects
Goldman Sachs Analyst forecast on DVAX
Paul ChoiGoldman Sachs
Goldman Sachs
$12$10
Sell
0.50%
Upside
Reiterated
04/16/25
Dynavax Technologies (DVAX) PT Lowered to $10 at Goldman SachsGoldman Sachs analyst Paul Choi lowered the price target on Dynavax Technologies (NASDAQ: DVAX) to $10.00 (from $12.00) while maintaining a Sell rating.
H.C. Wainwright Analyst forecast on DVAX
Edward WhiteH.C. Wainwright
H.C. Wainwright
$31
Buy
211.56%
Upside
Reiterated
02/21/25
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN), Dynavax (NASDAQ: DVAX) and Irhythm Technologies (NASDAQ: IRTC)We are maintaining our full-year 2025 diluted EPS estimate of $0.35.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on DVAX
TipRanks AITipRanks
Not Ranked
TipRanks
$9.5
Hold
-4.52%
Downside
Reiterated
05/15/25
Dynavax's overall score is affected by weak financial performance due to declining revenues and net losses, which are somewhat offset by a strong balance sheet and adequate cash flow management. Technical indicators are bearish, and the stock's valuation is unappealing due to the negative P/E ratio. The earnings call provides a positive outlook with revenue growth and strategic advancements, which somewhat mitigates the financial and technical weaknesses. Continued focus on growth and cost management will be key to improving the company's financial health.
William Blair Analyst forecast on DVAX
Matt PhippsWilliam Blair
William Blair
Buy
Reiterated
06/04/25
William Blair Keeps Their Buy Rating on Dynavax (DVAX)
Citizens JMP Analyst forecast on DVAX
Roy BuchananCitizens JMP
Citizens JMP
$33$31
Buy
211.56%
Upside
Reiterated
05/07/25
Dynavax price target lowered to $31 from $33 at Citizens JMPDynavax price target lowered to $31 from $33 at Citizens JMP
TD Cowen Analyst forecast on DVAX
Phil NadeauTD Cowen
TD Cowen
$25
Buy
151.26%
Upside
Reiterated
05/06/25
Strong Buy Rating for Dynavax Amidst Promising Growth and Market Prospects
Goldman Sachs Analyst forecast on DVAX
Paul ChoiGoldman Sachs
Goldman Sachs
$12$10
Sell
0.50%
Upside
Reiterated
04/16/25
Dynavax Technologies (DVAX) PT Lowered to $10 at Goldman SachsGoldman Sachs analyst Paul Choi lowered the price target on Dynavax Technologies (NASDAQ: DVAX) to $10.00 (from $12.00) while maintaining a Sell rating.
H.C. Wainwright Analyst forecast on DVAX
Edward WhiteH.C. Wainwright
H.C. Wainwright
$31
Buy
211.56%
Upside
Reiterated
02/21/25
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN), Dynavax (NASDAQ: DVAX) and Irhythm Technologies (NASDAQ: IRTC)We are maintaining our full-year 2025 diluted EPS estimate of $0.35.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dynavax

1 Month
xxx
Success Rate
16/29 ratings generated profit
55%
Average Return
+7.61%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.17% of your transactions generating a profit, with an average return of +7.61% per trade.
3 Months
xxx
Success Rate
11/25 ratings generated profit
44%
Average Return
+1.42%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.00% of your transactions generating a profit, with an average return of +1.42% per trade.
1 Year
Matt PhippsWilliam Blair
Success Rate
18/29 ratings generated profit
62%
Average Return
+40.35%
reiterated a buy rating 3 days ago
Copying Matt Phipps's trades and holding each position for 1 Year would result in 62.07% of your transactions generating a profit, with an average return of +40.35% per trade.
2 Years
xxx
Success Rate
24/29 ratings generated profit
83%
Average Return
+62.29%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.76% of your transactions generating a profit, with an average return of +62.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DVAX Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Apr 25
May 25
Jun 25
Strong Buy
8
9
6
5
2
Buy
0
1
1
2
2
Hold
0
0
0
0
0
Sell
0
1
2
2
1
Strong Sell
0
0
0
0
0
total
8
11
9
9
5
In the current month, DVAX has received 4 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. DVAX average Analyst price target in the past 3 months is 22.00.
Each month's total comprises the sum of three months' worth of ratings.

DVAX Financial Forecast

DVAX Earnings Forecast

Next quarter’s earnings estimate for DVAX is $0.10 with a range of $0.03 to $0.14. The previous quarter’s EPS was -$0.77. DVAX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year DVAX has Outperformed its overall industry.
Next quarter’s earnings estimate for DVAX is $0.10 with a range of $0.03 to $0.14. The previous quarter’s EPS was -$0.77. DVAX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year DVAX has Outperformed its overall industry.

DVAX Sales Forecast

Next quarter’s sales forecast for DVAX is $85.57M with a range of $81.00M to $89.00M. The previous quarter’s sales results were $68.16M. DVAX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year DVAX has Preformed in-line its overall industry.
Next quarter’s sales forecast for DVAX is $85.57M with a range of $81.00M to $89.00M. The previous quarter’s sales results were $68.16M. DVAX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year DVAX has Preformed in-line its overall industry.

DVAX Stock Forecast FAQ

What is DVAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Dynavax Technologies Corp.’s 12-month average price target is 22.00.
    What is DVAX’s upside potential, based on the analysts’ average price target?
    Dynavax Technologies Corp. has 121.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DVAX a Buy, Sell or Hold?
          Dynavax Technologies Corp. has a consensus rating of Moderate Buy which is based on 3 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Dynavax Technologies Corp.’s price target?
            The average price target for Dynavax Technologies Corp. is 22.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $31.00 ,the lowest forecast is $10.00. The average price target represents 121.11% Increase from the current price of $9.95.
              What do analysts say about Dynavax Technologies Corp.?
              Dynavax Technologies Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of DVAX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis